バイオシミラーのグローバル市場動向...市場調査レポートについてご紹介

【英文タイトル】Global Biosimilars Industry

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Executive Summary

2. What are Biosimilars?

3. Emergence of Biosimilars
3.1 Role of the Biologics Price Competition and Innovation (BPCI) ACT
3.2 Issue of Data Exclusivity

4. Industry Definition
4.1 Defining Biosimilars
4.2 Specificity of Biosimilars
4.3 Categories of Biologics
4.4 Importance of Biosimilars
4.5 Comparing Biosimilars with Generics
4.6 Branded Product Business Model

5. Overview of the Biopharmaceutical Industry
5.1 Market Profile
5.2 Biopharmaceutical Manufacturing Process

6. Global Biosimilars Market Statistics
6.1 Market Profile
6.2 Market Size
6.3 Market Value of Branded Biologics Facing Patent Expiry
6.4 Operating Margin for Biosimilar Manufacturers
6.5 Investor Concerns regarding Biosimilars
6.6 Commercial Impact of the European Biosimilars Industry

7. Key Success Factors for Biosimilars
7.1 Long Term Strategy
7.2 Developing Competitive Intelligence
7.3 Proper Financial Structure
7.4 Developing Key Biomanufacturing Competencies
7.5 Developing Clinical Capabilities and Regulatory Expertise
7.6 Well Developed Sales and Distribution Channels

8. Factors Impacting the Global Biosimilars Industry
8.1 Growth of the Industry in Developed Countries
8.2 Growth of the Industry in BRIC Countries
8.3 High Cost of Biologics
8.4 Use of Branded Biologics to Increase
8.5 Introduction of Approval Pathways in the US and Japan
8.6 EU’s Draft on Biosimilar Monoclonal Antibody Guidance
8.7 Unfavorable Tendering Procedures
8.8 Problem of Reference Pricing
8.9 Strategy of Biosimilar Companies with Regards to Hospital and Retail Setting
8.10 Issue of Biosimilar Comparability
8.11 Lack of Incentives, Service Agreements and Marketing Costs
8.12 Availability of Second Generation Branded Biologics
8.13 No Automatic Substitution of Branded Biologics
8.14 Cost-containment to Boost Uptake of Biosimilars
8.15 Lack of Proper IP Protection in Emerging Countries
8.16 Ease of Market Entry in BRIC Countries
8.17 Strong Biologic Capabilities in BRIC Countries
8.18 Restricted Market Access for Domestic Players in Emerging Countries
8.19 Problem of Low Purchasing Power in Emerging Markets

9. Biosimilar Market Drivers & Challenges
9.1 Factors Driving Growth of Biosimilars
9.1.1 Need to Lower Healthcare Costs
9.1.2 Lower Development Costs of Biosimilars as compared to New Biologic Drug
9.1.3 Lower Cost of Treatment with Biosimilars
9.1.4 Upcoming Patent Expiries for Blockbuster Biologics
9.1.5 Large Sales of Biologic Drugs
9.1.6 Greater Profitability of Biosimilars as compared to Generic Drugs
9.2 Factors Restraining the Growth of Biosimilars
9.2.1 Lack of Automatic Substitution
9.2.2 High Cost of Development and Manufacturing as compared to Generics
9.2.3 High Entry Barriers to the Biosimilar Industry
9.2.4 Emergence of Second Generation Biologic Drugs
9.2.5 Patent Protection for Biologic Drugs

10. Regulatory Framework
10.1 Regulatory Framework in Europe
10.1.1 EMEA’s Current Position
10.1.2 Bolar Type Provision
10.1.3 Comparability Exercises
10.1.4 Approval Process for Biosimilars
10.2 Regulatory Framework in Japan
10.2.1 Current Position on Biosimilars
10.3 Regulatory Framework in the USA
10.3.1 BPCIA and the Approval Pathway for Biosimilars
10.3.1.1 Role of Biosimilarity and Interchangeability
10.3.1.2 FDA Regulations Biosimilars Approval and Regulation
10.3.1.3 Demonstration on Basis of Data
10.3.1.4 12 Years of Market and Data Exclusivity
10.3.1.5 Resolution to Patent Dispute
10.3.1.6 Notice of Commercial Marketing to Reference Product Sponsor
10.3.1.7 Substitution of Small Molecular Products
10.4 Differences between FDA & the EMEA
10.5 Issues with Momenta

11. Factors Determining Market Entry in the Global Biosimilar Industry
11.1 Long Drawn-out Biosimilar Clinical Development Timeline
11.2 Approval Pathways for Biosimilars
11.3 High Development Costs of Biosimilars
11.3.1 Costs in Developed Markets
11.4 Biosimilars Manufacturing in Developing Countries – Pros & Cons
11.4.1 Issues with Regulatory Approval
11.4.2 Clinical Trials
11.4.3 Cost of Research & Development
11.4.4 Manufacturing Barriers
11.5 Proving of ‘Biosimilarity’
11.6 Issues with EMA Draft Guidelines for Biosimilar MAb Approval
11.7 Challenges with Patents
11.8 Role of Market Exclusivity for Branded Biologics
11.9 Strategic Partnerships Driving the Industry
11.9.1 Role of M&A Deals
11.9.1.1 Merck & Co.
11.9.1.2 Pfizer
11.10 Lack of Proper Safety Regulations

12. Biosimilar Approval Pathways in the US and Europe

13. Competitive Landscape
13.1 Key Industry Players
13.2 Key Industry Suppliers
13.3 Generic Drug Producers
13.4 Key Investors in the Industry
13.5 Major Stakeholders in the Industry
13.6 Developed versus Emerging Markets
13.7 Biosimilar Launches
13.8 Analysis by Markets
13.8.1 Biosimilars in Australia
13.8.2 Biosimilars in BRIC Countries
13.8.3 Biosimilars in the European Union (France, Germany, Italy, Spain, the UK)
13.8.4 Biosimilars in Japan
13.8.5 Biosimilars in United States

14. Analysis of Major Biosimilars
14.1 Epoetin
14.2 Filgrastim
14.3 Somatropin

15. Upcoming Patent Expiries and Opportunities for Biosimilars

16. Strategies of Big Pharma to Combat Biosimilars

17. Country-wise Biosimilar Market Analysis
17.1 France
17.1.1 Overview of the Healthcare System
17.1.2 Pricing and Reimbursement
17.1.3 Drivers & Challenges for Biosimilars in France
17.2 Germany
17.2.1 Overview of the Healthcare System
17.2.2 Pricing and Reimbursement
17.2.3 Drivers & Challenges for Biosimilars in Germany
17.3 India
17.4 Italy
17.4.1 Overview of the Healthcare System
17.4.2 Pricing and Reimbursement
17.4.3 Drivers & Challenges for Biosimilars in Italy
17.5 Japan
17.6 Spain
17.6.1 Overview of the Healthcare System
17.6.2 Pricing and Reimbursement
17.6.3 Drivers & Challenges for Biosimilars in Spain
17.7 United Kingdom
17.7.1 Overview of the Healthcare System
17.7.2 Pricing and Reimbursement
17.7.3 Drivers & Challenges for Biosimilars in the UK
17.8 United States

18. Major Industry Players
18.1 Dr. Reddy’s Laboratories Limited
18.1.1 Company Overview
18.1.2 Business Segments
18.1.3 Presence in Biosimilars Market
18.1.4 SWOT Analysis
18.2 Hospira Inc
18.2.1 Company Overview
18.2.2 Business Segments
18.2.3 Presence in Biosimilars Market
18.2.4 SWOT Analysis (Brief Analysis)
18.3 Sandoz International
18.3.1 Company Overview
18.3.2 Business Segments
18.3.3 Presence in Biosimilars Market
18.3.4 SWOT Analysis
18.4 STADA Arzneimittel AG
18.4.1 Company Overview
18.4.2 Business Segments
18.4.3 Presence in Biosimilars Market
18.4.4 SWOT Analysis
18.5 Teva Pharmaceutical Industries
18.5.1 Company Overview
18.5.2 Business Segments
18.5.3 Presence in Biosimilars Market
18.5.4 SWOT Analysis
18.6 Watson Pharmaceuticals
18.6.1 Company Overview
18.6.2 Business Segments
18.6.3 Presence in Biosimilars Market
18.6.4 SWOT Analysis
18.7 3SBio Inc.
18.8 Biocon Limited
18.9 Biopartners Gmbh
18.10 Celltrion Inc
18.11 Intas Biopharmaceuticals
18.12 Kyowa Hakko Kirin Co., Ltd.
18.13 Reliance Life Sciences
18.14 Shanghai Fosun Pharmaceutical (Group) Co., Ltd
18.15 Wockhardt

19. Global Biosimilars Market Outlook
19.1 Market Outlook
19.2 Forecast for Biosimilar Sales
19.3 Forecast for US Biosimilars Market
19.4 Forecast for European Biosimilars Market
19.5 Forecast for Japanese Biosimilars Market
19.6 Forecast for Biosimilars
19.6.1 Biosimilars for Monoclonal Antibodies against Cancer
19.6.2 Erythropoietin (EPO) Biosimilars Markets
19.6.3 Human Growth Hormone (hGH) Biosimilars Markets
19.6.4 Granulocyte – Colony Stimulating Factor (G-CSF) Biosimilars Markets
19.6.5 Insulin and Insulin Analogs Biosimilars
19.6.6 Interferon alfa Biosimilars
19.6.7 Interferon beta Biosimilars
19.6.8 TNF alfa Inhibitor Biosimilars

20. Appendix

21. Glossary


【レポート販売概要】

■ タイトル:バイオシミラーのグローバル市場動向
■ 英文:Global Biosimilars Industry
■ 発行日:2014年5月
■ 調査会社:Taiyou Research
■ 商品コード:Taiyou-40619074
■ 調査対象地域:グローバル
  • 世界のスマートフォン用パワー・マネージメントIC市場(2014-2018)
    About Smartphone Power Management Integrated Circuit Power management integrated circuits are used to manage power requirements and support voltage scaling and power delivery sequencing in power electronic devices. They are the key components in any electronic device with a power supply, battery, or power cord, and optimize power usage. They are used in electronic systems such as cellphones, TVs, …
  • 通信キャリアのコンテンツデリバリネットワーク(CDN)戦略
    This report explores telecom carriers’ strategies with respect to content delivery networks (CDN). It analyses the impact of telcos’ arrival into the CDN value chain, especially with respect to pure-player CDN companies and equipment suppliers. It concludes with an analysis of the market that telcos can expect to capture over the long term, especially in the realm of mobile solutions which today a …
  • オシロスコープの世界市場2017-2021
    About Oscilloscopes An oscilloscope is a testing and measuring device used to monitor voltage or current passed to or from an electronic component or device. Oscilloscopes were originally available only in analog; however, digital versions of these devices are available currently. A digital oscilloscope requires an analog-to-digital converter (ADC) to convert voltage into digital information. It s …
  • 企業合成アプリケーションモニタリングの世界市場予測:APIモニタリング、SAASアプリケーション、モバイルアプリケーション、ウェブアプリケーション
    MarketsandMarkets forecasts the enterprise synthetic application monitoring market size to grow from USD 919.2 Million in 2016 to USD 2,109.7 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 18.1%. Enterprise synthetic monitoring process is instrumental in methodically and proactively monitor the network and application performance using external agents, which intimates the actual end u …
  • 心臓モニタリング及び診断装置(医療機器)のグローバル市場(2012-2018)
    The Cardiac Monitoring and Diagnostic Devices market is expected to reach US$2.3 billion by 2017 primarily supported by the segments: types - Telemetry Systems, ECG Devices and Holter Monitor. Globally, Event Monitors and ECG Devices together account for approximately 33% of the market are expected to support the Cardiovascular Devices industry going forward. Geographical analysis shows that the h …
  • 断熱材の世界市場:ファイバーグラス、フェノール樹脂フォーム、ポリスチレンフォーム、ポリウレタンフォ—ム
    Cold Insulation materials are used to prevent heat loss or heat gain to conserve the valuable energy. These materials have the ability to save the environment from ozone layer depletion and emission of greenhouse gases as they are high on hydrocholorofluorocarbons (HCFCs). Cold insulation is a technology that is used to reduce energy leakages from infrastructure to improve energy efficiency. Cold …
  • 中東・アフリカの大人用おむつ市場
    About Adult DiapersThe adult diaper market in MEA is still in its nascent stage. The social stigma related to adult diapers is still prevalent in this region. Adults diagnosed with urinary incontinence often feel embarrassed to wear diapers and are uncomfortable discussing their problems with physicians. However, manufacturers are collaborating with hospitals in the region to educate consumers abo …
  • メタノールのグローバル市場動向
    The global methanol market is anticipated to grow at the rate of over ten percent in the coming five years. Key factor driving market growth includes growing consumption of methanol in Asia-Pacific, especially in the Chinese market. In addition, the increasing use of methanol across various end-use segments including alternative fuels and acetic acid is expected to drive the market growth. Asia-Pa …
  • 世界の家電産業における2Dジェスチャ認識市場
    About 2D gesture recognition technology 2D gesture recognition technology can be integrated into any device that has a 2D camera, which makes them very cost-effective. Technavio's analysts forecast the global 2D gesture recognition market in consumer electronics to grow at a CAGR of 20.9% the period 2014-2019. [Covered in this report] Technavio's report, Global 2D Gesture Recognition Market in Con …
  • 直接メタノール燃料電池(DMFC)の世界市場予測(~2020)
    The Direct Methanol Fuel Cells (DMFC) market is expected to reach USD 188.82 Million by 2020, at a CAGR of 15.3% from 2015 to 2020. The growing demand for clean energy has been accompanied by depletion of fossil fuels, which has shifted the focus toward fuel cell markets. The DMFC market is still in its initial development phase in all the regions due to slow infrastructure development for refueli …
  • 乾癬治療薬の世界市場予測・分析
    PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024 Summary Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Although not life-threatening, Psoriasis causes tremendous morbidity and person …
  • データレイクの世界市場:データ・ディレクトリー、データ統合、データレイク分析、データ可視化
    The data lakes market size is expected to grow from USD 2.53 Billion in 2016 to USD 8.81 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 28.3% during the forecast period. The major growth drivers of the market include need for increased business agility and accessibility, increasing adoption of Internet of Things (IoT), potential for in-depth insights to drive competitive advantage, an …
  • 通信産業向け分析ソリューションの世界市場:顧客分析、ネットワーク分析、マーケット分析、価格分析、サービス分析ソフトウェア
    Communication is the process to facilitate the sender and receiver to exchange their ideas over a medium. The medium referred here is the communication channel offered by Communication Service Providers (CSP). With the growing number of subscribers, the channel is also burdened with congestion, fraud and unsatisfied customers which in turn brings down the efficiency and revenue for the telecom pro …
  • スマートウェルの世界市場2017-2021
    The global smart well market is expected to witness significant growth during the forecast period. The growth of the market is mainly attributed to the increasing demand for oil and gas across the globe. The development of this market is dependent on the efficiency of the smart well, advancement in equipment technology and the increase in investments by market vendors. The growth of smart well mar …
  • プリンターのグローバル市場動向
    Taiyou Research analyzes the global market for printers in its latest research report. The report takes a look at the global market for laser printers, color inkjet printers, monochrome laser printers and color laser printers. The report analyzes the printer market in Asia Pacific, Europe (particularly Western Europe) and the United States. Each region and segment is analyzed through average sales …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。